We are pleased to represent Chanelle Pharma, Ireland’s largest indigenous generic pharmaceutical manufacturer of both medical and veterinary products, on its sale to Exponent.

The Arthur Cox team was led by Michael Coyle and Kylie Dollard (Corporate and M&A) and included Niamh Gunning and Philippa Bourke (Corporate and M&A), Colin Kavanagh and Robert Byrne (Life Sciences), Orlaith Kane and Cristina Susanu (Tax), Patrick Horan, Sarah Gallagher and Ailbhe Ó Faoláin (Competition and Regulated Markets), Niav O’Higgins (Health and Safety), Ed McDonagh (Finance), Brian O’Rourke and Thelma Byrne (Real Estate) and Louise O’Byrne and Sally Doyle (Employment).

Read more here.